Coherus Oncology Inc (CHRS)

Net Change in Cash

-$107.61M

TTM · Period ending: · USD

CHRS logo

CHRS Net Change in Cash

Latest reported-$107.61M
CHRS TTM Net Change in Cash ($25.01M → -$107.61M)
High-resolution chart · PNG

CHRS net change in cash history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Net Change in Cash — Trailing twelve months (TTM) (USD)
Period endingNet Change in Cash (USD)
-107,611,000
32,827,000
-37,108,000
5,662,000
57,464,000
-177,552,999
22,907,001
16,790,001
85,880,001
243,190,000
38,904,000
-206,534,000
-202,564,000
-309,535,000
-353,648,000
-73,735,000
-54,254,000
66,191,000
-123,963,001
68,074,999
105,120,999
66,236,999
363,490,000
127,299,000
117,855,000
110,902,000
104,477,000
63,129,000
-24,078,000
-506,000
-54,565,000
-34,365,000
56,643,000
-42,913,000
1,964,000
-24,120,000
-147,564,000
-54,634,000
-33,279,000
5,986,000
14,828,000
64,422,000
7,834,000
52,816,000
97,219,000
58,819,000
110,838,000
66,159,000
105,582,000
48,994,000
25,006,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.